Page last updated: 2024-10-23

azathioprine and Acute Autoimmune Neuropathy

azathioprine has been researched along with Acute Autoimmune Neuropathy in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kim, S1
Lee, EK1
Sohn, E1
Patwala, K1
Crump, N1
De Cruz, P1

Other Studies

2 other studies available for azathioprine and Acute Autoimmune Neuropathy

ArticleYear
Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination.
    Journal of Korean medical science, 2023, Feb-27, Volume: 38, Issue:8

    Topics: 2019-nCoV Vaccine mRNA-1273; Ad26COVS1; Aged; Azathioprine; COVID-19; COVID-19 Vaccines; Guillain-Ba

2023
Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity.
    BMJ case reports, 2017, Jul-05, Volume: 2017

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Gastrointestinal Agents; G

2017